3.2(top 10%)
impact factor
274(top 50%)
papers
4.3K(top 20%)
citations
29(top 20%)
h-index
3.3(top 10%)
impact factor
583
all documents
5.6K
doc citations
54(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Hepatocellular carcinoma: a reviewJournal of Hepatocellular Carcinoma2016842
2Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significanceJournal of Hepatocellular Carcinoma2018155
3<p>LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance</p>Journal of Hepatocellular Carcinoma201993
4Hepatocellular carcinoma: epidemiology and risk factorsJournal of Hepatocellular Carcinoma201488
5Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventionsJournal of Hepatocellular Carcinoma201983
6The Mechanisms of HBV-Induced Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma202183
7Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective StudyJournal of Hepatocellular Carcinoma202171
8Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular PathwaysJournal of Hepatocellular Carcinoma202165
9<p>The Immune Modulation Effect of Locoregional Therapies and Its Potential Synergy with Immunotherapy in Hepatocellular Carcinoma</p>Journal of Hepatocellular Carcinoma202064
10GPC-3 in hepatocellular carcinoma: current perspectivesJournal of Hepatocellular Carcinoma201662
11Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment OptionsJournal of Hepatocellular Carcinoma202162
12Hepatocellular carcinoma: early-stage management challengesJournal of Hepatocellular Carcinoma201760
13<p>Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment</p>Journal of Hepatocellular Carcinoma202060
14Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategiesJournal of Hepatocellular Carcinoma201758
15Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a reviewJournal of Hepatocellular Carcinoma201756
16<p>Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date</p>Journal of Hepatocellular Carcinoma201955
17<p>Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives</p>Journal of Hepatocellular Carcinoma201954
18Pretreatment neutrophil&ndash;lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinomaJournal of Hepatocellular Carcinoma201853
19Pediatric hepatocellular carcinoma: challenges and solutionsJournal of Hepatocellular Carcinoma201749
20Liver Imaging Reporting and Data System: an expert consensus statementJournal of Hepatocellular Carcinoma201746
21Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutionsJournal of Hepatocellular Carcinoma201745
22Hepatocellular carcinoma: a review of diagnostic challenges for the pathologistJournal of Hepatocellular Carcinoma201844
23<p>Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging</p>Journal of Hepatocellular Carcinoma202044
24The Crosstalk Between Cancer Cells and Neutrophils Enhances Hepatocellular Carcinoma Metastasis via Neutrophil Extracellular Traps-Associated Cathepsin G Component: A Potential Therapeutic TargetJournal of Hepatocellular Carcinoma202143
25<p>Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2</p>Journal of Hepatocellular Carcinoma202041
26Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectivesJournal of Hepatocellular Carcinoma201740
27The androgen receptor as an emerging target in hepatocellular carcinomaJournal of Hepatocellular Carcinoma201539
28Fibrolamellar hepatocellular carcinoma: current clinical perspectivesJournal of Hepatocellular Carcinoma201539
29Hepatocellular carcinoma in elderly patients: challenges and solutionsJournal of Hepatocellular Carcinoma201636
30NAFLD-Associated HCC: Progress and OpportunitiesJournal of Hepatocellular Carcinoma202133
31Transarterial radioembolization for hepatocellular carcinoma: a reviewJournal of Hepatocellular Carcinoma201632
32Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinomaJournal of Hepatocellular Carcinoma201632
33<p>Development and Verification of the Hypoxia-Related and Immune-Associated Prognosis Signature for Hepatocellular Carcinoma</p>Journal of Hepatocellular Carcinoma202031
34Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma202130
35Emerging role of Toll-like receptor 4 in hepatocellular carcinomaJournal of Hepatocellular Carcinoma201529
36<p>Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date</p>Journal of Hepatocellular Carcinoma202029
37Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future DirectionsJournal of Hepatocellular Carcinoma202129
38Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma202129
39Emerging role of Hpo signaling and YAP in hepatocellular carcinomaJournal of Hepatocellular Carcinoma201528
40Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentaryJournal of Hepatocellular Carcinoma201628
41Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing TidesJournal of Hepatocellular Carcinoma202128
42Screening for hepatocellular carcinoma: patient selection and perspectivesJournal of Hepatocellular Carcinoma201727
43Systemic Therapy for Hepatocellular Carcinoma: Current Updates and OutlookJournal of Hepatocellular Carcinoma202227
44c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinomaJournal of Hepatocellular Carcinoma201526
45Surgical resection of localized hepatocellular carcinoma: patient selection and special considerationJournal of Hepatocellular Carcinoma201726
46Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challengeJournal of Hepatocellular Carcinoma201726
47Peritumoral Dilation Radiomics of Gadoxetate Disodium-Enhanced MRI Excellently Predicts Early Recurrence of Hepatocellular Carcinoma without Macrovascular Invasion After HepatectomyJournal of Hepatocellular Carcinoma202126
48<p>Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine</p>Journal of Hepatocellular Carcinoma201925
49<p>Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors</p>Journal of Hepatocellular Carcinoma202025
50Current Strategies to Identify Patients That Will Benefit from TACE Treatment and Future Directions a Practical Step-by-Step GuideJournal of Hepatocellular Carcinoma202125